Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing NaN - NaN of 89
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +139 more
Sep 9, 2022

Multiple Myeloma Trial in Canada (Busulfan, Melphalan, Lenalidomide)

Completed
  • Multiple Myeloma
  • Edmonton, Alberta, Canada
  • +9 more
Sep 20, 2022

Multiple Myeloma Trial (BCMA CAR T cells, BCMA/CD19 CAR T cells)

Enrolling by invitation
  • Multiple Myeloma
  • BCMA CAR T cells
  • BCMA/CD19 CAR T cells
  • London, County (optional), United Kingdom
    University College London Hospital
Sep 15, 2022

Haematological Malignancy, Acute Myeloid Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (CCS1477, Pomalidomide,

Recruiting
  • Haematological Malignancy
  • +4 more
  • Phoenix, Arizona
  • +14 more
Aug 22, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab)

Recruiting
  • Multiple Myeloma
  • Fort Collins, Colorado
  • +33 more
Aug 17, 2022

Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Orlando, Florida
  • +240 more
Aug 18, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin frozen liquid, Belantamab mafodotin lyophilized powder)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
Jul 27, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Yuma, Arizona
  • +34 more
Jul 22, 2022

Multiple Myeloma Trial in Worldwide (Lemzoparlimab, Dexamethasone, Carfilzomib)

Terminated
  • Multiple Myeloma
  • Lemzoparlimab
  • +4 more
  • Tucson, Arizona
  • +58 more
Jul 6, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Tucson, Arizona
  • +131 more
Jul 1, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Durvalumab, Pomalidomide)

Completed
  • Multiple Myeloma
  • Duarte, California
  • +43 more
Jun 9, 2022

Lymphoma, Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Dexamethasone (Oral))

Completed
Has Results
  • Lymphoma
  • Multiple Myeloma
  • Muscle Shoals, Alabama
  • +215 more
May 5, 2022

Multiple Myeloma Trial in United Kingdom (Pomalidomide, Dexamethasone, Cyclophosphamide)

Active, not recruiting
  • Multiple Myeloma
  • Belfast, United Kingdom
  • +20 more
May 24, 2022

Solid Tumours, Multiple Myeloma, Lung Cancer Trial in Sutton, London (VS-6766, Everolimus)

Recruiting
  • Solid Tumours
  • +2 more
  • Sutton, Surrey, United Kingdom
  • +1 more
Apr 25, 2022

Multiple Myeloma Trial in France, United Kingdom (CID-103)

Recruiting
  • Multiple Myeloma
  • Nantes, France
  • +3 more
Apr 21, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pom/dex (Pomalidomide plus low dose Dexamethasone))

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • Pom/dex (Pomalidomide plus low dose Dexamethasone)
  • Tucson, Arizona
  • +163 more
Feb 25, 2022

Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy, Multiple Myeloma, DLBCL Trial in

Enrolling by invitation
  • Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy
  • +4 more
  • AUTO CAR T cell therapy
  • London, United Kingdom
  • +3 more
Feb 2, 2022

Multiple Myeloma Trial in Canada (Carfilzomib, Cyclophosphamide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Edmonton, Alberta, Canada
  • +8 more
Feb 1, 2022

Multiple Myeloma Trial in Worldwide (Elotuzumab, Dexamethasone, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +37 more
Jan 14, 2022

Multiple Myeloma, Chronic Kidney Disease Trial in United Kingdom (Bortezomib, Thalidomide, Bendamustine)

Completed
Has Results
  • Multiple Myeloma
  • Chronic Kidney Disease
  • Basingstoke, United Kingdom
  • +8 more
Jan 26, 2022

Multiple Myeloma Trial in Worldwide (Elotuzumab, Pomalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Atlanta, Georgia
  • +54 more
Jan 11, 2022

Multiple Myeloma Trial in Worldwide (Selinexor, Bortezomib, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Plantation, Florida
  • +156 more
Nov 23, 2021

Multiple Myeloma Trial in Worldwide (HLA Matched allogeneic transplant)

Completed
  • Multiple Myeloma
  • HLA Matched allogeneic transplant
  • Wien, Austria
  • +23 more
Oct 5, 2021

Biology and Genetics of Smouldering Myeloma

Recruiting
  • Smouldering Myeloma
  • +2 more
  • No intervention
  • London, United Kingdom
    University College London Hospitals
Sep 15, 2021

Multiple Myeloma Trial in Worldwide (Pomalidomide and Dexamethasone)

Completed
  • Multiple Myeloma
  • Pomalidomide and Dexamethasone
  • Linz, Austria
  • +21 more
Aug 25, 2021